Oncostatin M expression induced by bacterial triggers drives airway inflammatory and mucus secretion in severe asthmaSarah E. Headland, Mark S. Wilson, Donghong Yan et al.|Science Translational Medicine|2022Cited by 56
Argonaute3-SF3B3 complex controls pre-mRNA splicing to restrain type 2 immunityRiccardo Guidi, Mark S. Wilson, Christopher J. Wedeles et al.|Cell Reports|2023Cited by 6
Combined antagonism of Oncostatin M (OSM) and Interleukin 6 (IL-6) provides both anti-fibrotic and anti-inflammatory benefit in pulmonary fibrosisRojo Ratsimandresy, Mark S. Wilson, Emma Doran et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 0